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INTRODUCTION
Cytokines are proteins that are produced by immunocompetent cells, controlling immune activity within the cell or at a distance. Cytokines mediate immunologic cross-talk between and within immune cells, and play a major part in inflammatory responses.
The Interleukin 1 (IL-1) gene family consists of IL-1α, IL-1β, and IL-18 and six additional putative ligand members have been reported 1 . The IL-1 family also includes a naturally occurring competitive IL-1 receptor antagonist (IL-1RA) 2 . IL-1α
and IL-1β have similar biological activities and are generally known as highly inflammatory cytokines 2 . They are produced by various immune cells and IL-1α is constitutively expressed by epithelial, endothelial cells, fat and microglia cells 3 . Also, keratinocytes constitutively produce large amounts of precursor IL-1α in healthy human skin 4 . Monocytes, macrophages and CD4 + T cells are known to produce IL-1α only after stimulation by various exogenous and endogenous stimuli 5, 6 .
Both IL-1α and IL-1β are synthesized as precursors without leader sequences and processing of the precursors to 'mature' proteins requires specific cellular proteases.
The IL-1α proform is bioactive in contrast to the IL-1β proform 2 and is not commonly found in the circulation or in body fluids, except during severe disease 6 .
IL-1 is the dominant cartilage destructive cytokine in animal models 7 in which a deficiency of IL-1RA relative to IL-1 leads to more severe autoimmune disease and to the spontaneous development of arthritis 8 . These studies suggest that IL-1 expression needs to be tightly regulated.
Recently, there have been various reports on monoallelic expression of murine and human cytokines like IL-2 9 , IL-4 10 , GMCSF 10 , and also other proteins such as p120 catenin 11 , TLR4 12 , Pax5 13 and Perforin 14 . Previously we, and others 15 , have shown stable non-imprinted (random), imbalanced allelic expression of IL-1α in human CD4 + T cell clones (TCC) in which either one of the alleles is strongly favored (>8-16-fold) 16 . This indicates that allelic differences in gene expression ("allelic imbalances") could provide an additional level of regulation of gene expression. 4 show that many genes do not express both alleles of autosomal genes at equal levels 15 .
Here, we investigated whether the allele-specific activation or silencing is established by an epigenetic mechanism. Methylation of CpG dinucleotides is an epigenetic mechanism used for silencing of long term gene expression and serves to recruit histone deacetylases, histone methyltransferase, and chromatin remodeling complexes that promote a closed chromatin structure 17 . Hypermethylation of DNA has been negatively correlated with gene expression in many cases, and is thought to exert its repressive effects on transcription by inhibiting the binding of transcription factors to their cis-element and also indirectly via the recruitment of methyl-DNA-binding proteins 18 .
Mammals exhibit several epigenetic phenomena that prevent simultaneous gene expression from both alleles of a given locus like non-imprinted (random) X chromosome inactivation in females, nonrandom parental imprinting of selected autosomal genes, allelic exclusion of antigen receptors in lymphocytes and odorant receptor gene clusters in olfactory sensory neurons 9 . IL-1α, like other cytokine genes, does not reveal any of the features like recombinase-activation gene (RAG)-mediated cleavage established for loci known to be allelically excluded 19 . The IL-1α gene is not a known target of parental imprinting. Recently it has been shown that transcription of NK cell receptors (KIR genes), which are present in a cluster of genes, precisely correlates with allele-specific DNA methylation 20, 21 .
IL-1α is localized on human chromosome 2 and is encoded by a single gene. Little is known about the regulation of human IL-1α expression. It has been reported that several regions are involved in inducible gene expression, including a GC-rich element, containing CpGs just upstream of the transcription start site 6, 22, 23 . The IL-1α
5' flanking region contains multiple CpG nucleotides that could render this locus susceptible to epigenetic regulation by DNA methylation. It is thus an attractive hypothesis that allele-specific expression of IL-1α is associated with allele-specific methylation.
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MATERIALS AND METHODS
Cells
Human T cell clones were prepared and cultured as described before 16 .
CD45RA
+ CD45RO -naive CD4 + Th cells were isolated from PBMC from healthy individuals by MACS isolation as described before 24 or facs flow sorted.
Keratinocytes were isolated from foreskin as described before 25 . The IL-1α nonexpressing cell line used in one of the experiments is the Namalwa cell line, a human lymphoblastoid cell line established from a Burkitt's lymphoma patient.
Drug treatment
For treatment, restimulated T cell clones or Namalwa cells were seeded at a density of 1x10 6 cells/ml and treated with 0.1 µM, 1 µM or 2 µM 5-aza-CdR for 24 h.
Subsequently, the medium was changed and cells were cultured for 48 h. The T cell clones cells were stimulated for 6h with PMA (5 ng/ml) and ionomycin (250 ng/ml).
RNA and DNA extraction
Total RNA isolation was performed using the RNeasy kit (Qiagen, Leusden, The Netherlands) according to the manufacturers instructions including a DNase treatment. Genomic DNA was isolated with the DNeasy kit (Qiagen). PCR products were purified from gel with QIAEX II agarose gel extraction kit (Qiagen) or Qiaquick column purification (Qiagen).
5' RACE
The 5' end of IL-1α mRNA was determined using the RLM-RACE kit (Ambion, 5' RLM-RACE PCR product was cut out from a 2% agarose gel, purified using the 
Detection of DNA methylation
The bisulfite conversion of genomic DNA was adapted from Frommer et al. 27 with some modifications. 1-3.5 µg of DNA in a volume of 60 µl was treated with bisulfite and purified on a P30 column (Biorad, Veenendaal, The Netherlands). We have also used the EZ DNA Methylation kit (ZYMO research, Leiden, The Netherlands), obtaining similar results. After modification with bisulfite, 40~150 ng of bisulfite treated DNA was used to amplify specific regions by PCR: a 2' denaturation step was followed by 5 cycles of 1' at 94ºC, 2' at 50ºC and 3' at 72ºC, and 25 cycles of 30 s at 94ºC, 2' at 50ºC and 1.5' at 72ºC. The PCR products were amplified using a nested set of primers with the same amplification program. Primers specific for bisulfiteconverted DNA were designed, and used as follows: DNA molecules of the promoter region were analyzed in three parts, namely containing CpG site -13 and -12;
containing CpG sites -11-10-9-8; and containing CpG sites -8 or -7 through -1 or +1;
CpG sites in intron IV were analyzed in a fragment containing CpG sites +17 through +29. After amplification of bisulfite converted DNA, methylation levels were either measured on several CpGs (-8, -7, -2 or +1) by methylation-sensitive single 28 or by sequencing of cloned PCR products. To this aim PCR products were purified using the QIAEXII Agarose gel extraction kit (Qiagen) and cloned using pGEM-T Easy Cloning kits (Promega, Leiden, The Netherlands) or TOPO TA cloning kit (Invitrogen, Breda, The Netherlands). More than 9 cloned fragments were sequenced for each amplified region of each clone or cell type. Sequences were determined using the BigDye Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems) on an ABI 3100 sequencer and analyzed with ABI prism™ 310 collection software. Sequences for primers for bisulfite-PCR and Ms-SNuPE can be obtained upon request.
Labeling of probes and Electrophoretic mobility shift assay (EMSA)
An EMSA was performed as described before 22 , with some minor modifications.
Briefly, 400 ng of ssDNA was end labeled with T4 polynucleotide kinase (NEB, Ipswich, MA) using 3 µl γ 32 P-ATP (6000 Ci/mM) according to manufacturer's instructions in a volume of 50 µl and purified using the Quick Spin Columns (Roche Diagnostics, Indianapolis, IN). After precipitation, the pellet was dissolved and annealed in 2 µl 10x annealing buffer (10 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl 2 , 1 mM EDTA and 1 mM DTT)), 14 µl dH2O and 600 ng opposing strand oligonucleotide. The binding reaction with HaCaT or Namalwa nuclear extracts (prepared as described before 29 ) was incubated on ice for 30 min. Unlabeled competitor ds-oligonucleotides were added to the reaction mix prior to the protein extract. The wild type ds-oligonucleotide used was -68 through -42 relative to the transcripton start site: 5'-ACT TGT AGC CAC GTA GCC ACG CCT ACT-(-42)-3'
22
. For the methylated oligonucleotide the methylation was introduced at the cytosines (bold face) in the CpG dinucleotides at both strands (Operon, Huntsville, AL). The Sp1 ds-oligonucleotide was 5'-ATT CGA TCG GGG CGG GGC GAG C-3'. The whole sample was loaded on a 6% polyacrylamide gel in 0.5x TBE.
RESULTS
Transcription start site of IL-1α in lymphocytes.
The genome database contains several IL-1α mRNA transcripts, suggesting that there are 2 or more transcription start sites (TSSs). GenBank (NM_000575) is a transcript with a long 5' UTR of about 960 nucleotides (n) (TSS2).
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From van Rietschoten et al. 8 Another transcript with a much shorter 5' UTR, of 59 bp was also reported, which was determined by primer extension (TSS1) 30 . It was demonstrated that the region upstream of TSS1 acts as a promoter able to control the expression of a reporter gene 22 . To determine which of the two TSSs are used in stimulated lymphocytes, we performed a 5'-rapid amplification of cDNA ends (RACE) analysis using transcriptspecific primers ( Figure 1 ). A PCR product was detected with the TSS1 gene specific primers, but not with the TSS2 gene specific primers. The product was subcloned and sequenced with a nested gene-specific primer, which showed that the 5' end of the mRNA was 59 bp upstream of the ATG. This transcription start site (TSS1) was confirmed by RT-PCR on RNA from stimulated CD4 + T cells from different donors (data not shown). We therefore conclude that the core-promoter directing transcription in lymphocytes starts 59 bp upstream of the ATG.
IL-1α promoter methylation in constitutively IL-1α expressing keratinocytes is
restricted to a confined region. We first determined the methylation status of CpG dinucleotides in the IL-1α proximal promoter in keratinocytes that constitutively produce IL-1α 4 . Therefore, we used bisulfite genomic sequencing to examine the methylation status of between -1 kb upstream and +77 bp downstream of the transcription start site. This region contains 14 CpG sites (labeled -13 through +1 as shown in Figure 1 ). This cluster of 14 CpG sites in the IL-1α promoter region -1kb through +76bp is not identified as a CpG island, as calculated by the CpG Island Searcher 31 . The region was examined by three PCRs which produced partially overlapping sequences. This revealed that the CpGs -7 through +1 are mostly unmethylated, while CpG -8 through -12 showed partial methylation. CpG -13 was always fully methylated ( Figure 2a) . A similar pattern was observed in the keratinocyte cell line HaCaT 32 (data not shown). Subsequently, we analyzed the methylation of 13 CpGs (+17 through +29) in intron IV which showed that these intronic CpGs were all methylated, except for the most 5' CpG (CpG +17, Figure 2b ).
In conclusion this shows that in cells constitutively expressing IL-1α, the CpGs within 130 bp from the transcription start site are unmethylated, whereas other CpGs are mostly methylated. Further studies were therefore directed to the proximal promoter region containing CpGs -7 through +1.
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Differential methylation of IL-1α in allele-specific IL-1α expressing T cell clones.
We next analyzed the methylation status of the CpGs in the IL-1α proximal promoter region in allele-specific expressing T cell clones. This revealed that the CpGs -7 through +1 were either almost all unmethylated or all methylated in three representative T cell clones (Figure 3a-c) .
As expected, bisulfite sequencing of the 13 CpG sites (+17 through +29) in intron IV revealed that CpG +18 through +29 were almost all found to be methylated on both alleles as was observed in DNA isolated from keratinocytes. Only CpG +17 showed differential methylation (Figure 3a-c) . Similar results were obtained for the intron IV CpGs with other T cell clones exhibiting allele-specific expression. Taken together this shows that differential methylation of only CpGs -7 through +1 in the proximal promoter region is associated with allele-specific gene expression.
Treatment with 5-aza-CdR induces IL-1α mRNA expression in non-expressing cells.
We next analyzed the methylation status of the lymphoblastoid Namalwa cell line, which does not express IL-1α. The methylation of CpGs +1, -2 and -7, which were differentially methylated in the proximal promoter of the T cell clones, was measured by methylation sensitive single nucleotide primer extension (Ms-SNuPE) analysis. As a control we included a CpG which was shown to be highly methylated in keratinocytes . This revealed that the CpG at -8 was highly methylated in all cells (Figure 4a ). In contrast, the three CpGs found to be differentially methylated in the T cell clones, were highly methylated in the non-expressing Namalwa cells and 
proximal promoter region and intron IV bisulfite sequencing was performed on DNA isolated from naive T cells. The methylation pattern in naive T cells was analyzed for CpGs -7 through -1 ( Figure 6 ). Interestingly, the bisulfite sequencing revealed a similar methylation pattern as observed in the differentiated T cell clones. The proximal promoter CpGs (CpG -7 through -1) were either completely methylated or unmethylated. Also, the CpG sites +18 through +29 in intron IV from both alleles were highly methylated (Figure 6 ), as we have seen in keratinocytes and T cell clones.
These methylation patterns were also found in cells from a second donor (data not shown). This analysis shows that both naive and differentiated T cells contain methylated and unmethylated IL-1 promoter alleles, suggesting that differential methylation of the alleles is already established before the formation of naive T cells.
DNA/protein binding at the proximal promoter region is significantly reduced by methylation of CpGs -2 and -3. EMSA was performed to compare the binding characteristics of the unmethylated versus the methylated ds-oligonucleotide
containing CpGs -2 and -3. This sequence contains a specific region that was shown to be protected by DNase I footprinting and showed transcription factor binding in We next investigated whether the wild type ds-oligonucleotides also formed the methylation sensitive complex with nuclear proteins isolated from IL-1α nonexpressing cells. Therefore, nuclear protein from Namalwa cells were incubated with
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HaCaT nucear extracts. The nuclear protein extracts from Namalwa cells were able to form complex c3, the methylation sensitive complex c1 and also complex c2, but to a lesser extend (Figure 7b, lane 1) . As was also seen with the HaCaT nuclear proteins, the formation of the methylation sensitive complex c1 was completely abrogated with the methylated probe (Figure 7b, lane 6) . Accordingly, c1 formation is dosedependently inhibited by competition with a 20-or 200-fold molar excess of unlabeled wild type probe, whereas the methylated unlabeled probe is much less efficient to compete for binding (compare c1 lane 2 and 3 with 4 and 5, respectively).
These findings indicate that non-expressing cells, which have a fully methylated IL-1α promoter (Figure 4a ), contain transcription factors that are able to bind to an unmethylated promoter but that binding is inhibited by CpG methylation.
Previously, it has been shown that Sp1 binds sequences within the region examined 23 .
We therefore performed an EMSA with a wild type probe and Sp1 probe as a control.
Incubation with the wildtype probe resulted in the formation of the three complexes 
DISCUSSION
Here, we investigated DNA methylation in the proximal promoter region of the IL-1α gene, to see whether DNA methylation might be involved in the allele-specific expression of IL-1α in CD4 + T cells. We showed that the CpGs -7 through +1 relative to the transcription start site within a region of 130 bp, are differentially methylated.
The patterns found correlate with the expression of IL-1α in the cell types examined.
In expressing keratinocytes, the CpGs of both alleles are hypomethylated, in non expressing cells the CpGs are hypermethylated, and in predominant allele-specific expressing CD4 + T cells, alleles were either hypermethylated or hypomethylated. This differential methylation appears to be confined to the promoter region as no Little is known about the regulation of IL-1α expression, but it is interesting to note that a specific region in the proximal promoter containing the differentially methylated CpGs we have studied, has been shown to be important for transcriptional regulation of IL-1α. Zaldivar et al. 22 analyzed the -224 to +5 proximal promoter region, which drives transcription from TSS 1 and contains the differentially methylated CpGs. Several investigators have confirmed the importance of this region for promoter activity by showing that deleting the region between -63 to -49 significantly affects the expression of IL-1α in a variety of cell lines 34, 35 . By DNase I
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From footprint analysis it was shown that several regions are protected 22, 23 . Mutations within a triple GCC repeat that was shown to bind transcription factors at the -65 to -41 protected area, reduced promoter activity by 90% and also affected the protein/DNA binding properties to this GCC element 22 . Recently it was shown that a binding site for Sp1 is present within this -52 to +64 region 23 , which we could confirm in this study by EMSA. We have shown that methylation of these CpGs It is known that epigenetic mechanisms operate during differentiation of naive T cells into Th1 and Th2 cells to result in the precise expression or silencing of cytokines. For IL-2 it has been shown that the immediate proximal promoter region containing 8
CpGs are demethylated in activated T lymphocytes. These epigenetic changes are necessary and sufficient for transcription 36 . We show that methylation of two CpGs in the IL-1α proximal promoter, which were differentially methylated in the CD4 + T cells, resulted in direct inhibition of binding of nuclear factor(s), which consequently would affect transcription activity. In naive T cells, IL-4 is hypermethylated in the 5' regulatory region of the promoter which is specifically demethylated in Th2 cells 37 .
Also, a distinct region of the IFNγ promoter, containing a similar number of CpGs within 300 bp of the TSS as the IL-1α promoter, is hypomethylated in differentiated T lymphocytes 38 . Many of these cytokines have been reported to exhibit allele-specific expression 9, 10 . In a recent study by Allen et al 39 it is shown that known monoallelically expressed genes are flanked by high concentrations of long I  II  III  IV  V  VI  I  II  III  IV  V  VI   1  2  3  4  5  6 For personal use only. on September 24, 2017. by guest www.bloodjournal.org From 
